AU5732694A - Humanized antibodies reactive with cd18 - Google Patents

Humanized antibodies reactive with cd18

Info

Publication number
AU5732694A
AU5732694A AU57326/94A AU5732694A AU5732694A AU 5732694 A AU5732694 A AU 5732694A AU 57326/94 A AU57326/94 A AU 57326/94A AU 5732694 A AU5732694 A AU 5732694A AU 5732694 A AU5732694 A AU 5732694A
Authority
AU
Australia
Prior art keywords
humanized antibodies
antibodies reactive
reactive
humanized
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU57326/94A
Inventor
Man Sung Co
Nicholas F Landolfi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PDL Biopharma Inc
Original Assignee
Protein Design Labs Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Protein Design Labs Inc filed Critical Protein Design Labs Inc
Publication of AU5732694A publication Critical patent/AU5732694A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C07K16/2845—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta2-subunit-containing molecules, e.g. CD11, CD18
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU57326/94A 1992-12-01 1993-11-30 Humanized antibodies reactive with cd18 Abandoned AU5732694A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US98394992A 1992-12-01 1992-12-01
US983949 1992-12-01
PCT/US1993/011611 WO1994012214A1 (en) 1992-12-01 1993-11-30 Humanized antibodies reactive with cd18

Publications (1)

Publication Number Publication Date
AU5732694A true AU5732694A (en) 1994-06-22

Family

ID=25530202

Family Applications (1)

Application Number Title Priority Date Filing Date
AU57326/94A Abandoned AU5732694A (en) 1992-12-01 1993-11-30 Humanized antibodies reactive with cd18

Country Status (2)

Country Link
AU (1) AU5732694A (en)
WO (1) WO1994012214A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994004679A1 (en) * 1991-06-14 1994-03-03 Genentech, Inc. Method for making humanized antibodies
US6800738B1 (en) 1991-06-14 2004-10-05 Genentech, Inc. Method for making humanized antibodies
US6407213B1 (en) 1991-06-14 2002-06-18 Genentech, Inc. Method for making humanized antibodies
GB9115364D0 (en) 1991-07-16 1991-08-28 Wellcome Found Antibody
SE9500148D0 (en) * 1995-01-18 1995-01-18 Bioinvent Internatioal Ab Antibodies for use in cancer therapy and diagnosis
US5914112A (en) * 1996-01-23 1999-06-22 Genentech, Inc. Anti-CD18 antibodies in stroke
US20020081294A1 (en) 1996-01-23 2002-06-27 Genentech, Inc. Co-administration of a thrombolytic and an anti-CD18 antibody in stroke
EP0877626B1 (en) * 1996-01-23 2002-08-28 Genentech, Inc. Anti-cd18 antibodies for use against stroke
US7147851B1 (en) 1996-08-15 2006-12-12 Millennium Pharmaceuticals, Inc. Humanized immunoglobulin reactive with α4β7 integrin
US6312689B1 (en) 1998-07-23 2001-11-06 Millennium Pharmaceuticals, Inc. Anti-CCR2 antibodies and methods of use therefor
US6727349B1 (en) 1998-07-23 2004-04-27 Millennium Pharmaceuticals, Inc. Recombinant anti-CCR2 antibodies and methods of use therefor
US6696550B2 (en) 1998-07-23 2004-02-24 Millennium Pharmaceuticals, Inc. Humanized anti-CCR2 antibodies and methods of use therefor
JP3711326B2 (en) * 1998-10-28 2005-11-02 ジェネンテック・インコーポレーテッド Method for recovering heterologous polypeptides from bacterial cells
AU2001245781A1 (en) * 2000-03-17 2001-10-03 Millennium Pharmaceuticals, Inc. Cd18-binding antibodies inhibit stenosis-related disorders
WO2001070266A2 (en) * 2000-03-17 2001-09-27 Millennium Pharmaceuticals, Inc. Method of inhibiting stenosis and restenosis with a mixture of antibodies anti cd18 and anti ccr2
UA116189C2 (en) 2011-05-02 2018-02-26 Мілленніум Фармасьютікалз, Інк. FORMULATION FOR ANTI-α4β7 ANTIBODY
KR101884406B1 (en) 2011-05-02 2018-08-02 밀레니엄 파머슈티컬스 인코퍼레이티드 FORMULATION FOR ANTI-α4β7 ANTIBODY

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5147637A (en) * 1988-06-07 1992-09-15 The Rockefeller University Method of inhibiting the influx of leukocytes into organs during sepsis or other trauma
NZ236792A (en) * 1990-01-19 1993-05-26 Merck & Co Inc Recombinant human anti-cd18 antibody, murine 1b4 heavy or light chain variable region, dna, vectors, mammalian host and pharmaceutical compositions

Also Published As

Publication number Publication date
WO1994012214A1 (en) 1994-06-09

Similar Documents

Publication Publication Date Title
AU4025193A (en) Humanized C-erbB-2 specific antibodies
HU9501564D0 (en) Humanized antibodies reactive with l-selectin
AU4618193A (en) Humanized antibodies
AU4042195A (en) Anti-alphaV-integrin monoclonal antibody
ZA949341B (en) Humanized antibodies and uses thereof
AU5141193A (en) Monoclonal antibodies to prostate cells
AU6527894A (en) Prevention of tumors with monoclonal antibodies against (neu)
AU625613B2 (en) Novel chimeric antibodies
AU1289795A (en) Monoclonal antibodies specific for human interleukin-5
AU5732694A (en) Humanized antibodies reactive with cd18
AU5283893A (en) Recombinant humanized anti-cytomegalovirus antibodies
AU5869596A (en) Anti-gp130 monoclonal antibodies
AU7041996A (en) Antibody specific for beta1->6N- acetylglucosamininyltransferase
AU6080794A (en) Antibodies directed against binding-associated epitopes
AU3459593A (en) Humanised antibody against hepatitis
GB9412166D0 (en) Retargetting antibodies
EP0578515A3 (en) Humanized monoclonal antibodies.
AU3330689A (en) Monoclonal antibodies
AU6155896A (en) Humanized antibodies to e-selectin
AU6725190A (en) Anti-platelet monoclonal antibody
AU4450389A (en) Anti-fucosylcermiade monoclonal antibody
AU3752089A (en) Bispecific antibodies
AU6059194A (en) Monoclonal antibodies to bovine cytokines
AU4195793A (en) Bispecific antibody
AU8547291A (en) Monoclonal antibodies against tenascin